Partnering news
- AstraZeneca and Karolinska Institutet PET Centre Announce Molecular Imaging Research Agreement
- 26 January 2012
- AstraZeneca and IMS Health announce real-world evidence collaboration in Europe
- 11 January 2012
- Targacept announces decision by AstraZeneca to advance AZD1446 in Alzheimer’s disease
- 5 January 2012
- Dynavax and AstraZeneca agree to conduct toxicology studies for TLR-9 agonist for asthma
- 21 December 2011
- AstraZeneca Enters into Option Agreement to Acquire New Class of Diabetes Assets from Prosidion
- 21 December 2011
- AstraZeneca and Chi-Med enter into global collaboration to co-develop and commercialise novel cancer therapy
- 21 December 2011
- AstraZeneca updates on olaparib and TC-5214 development programmes
- 20 December 2011
- Enlight Biosciences forms new partnerships with AstraZeneca and Novo Nordisk
- 15 December 2011
- AstraZeneca out-licenses imaging agent for amyloid detection to aid diagnosis of Alzheimer’s disease to Neoprobe
- 13 December 2011
- AstraZeneca to acquire generics company to broaden patient access to medicines in China
- 8 December 2011
- Groundbreaking scientific collaboration gives UK academia access to compounds to advance medical research
- 5 December 2011
- AstraZeneca commits an additional $100 million to venture capital arm MedImmune Ventures
- 28 November 2011
Our areas of interest
This brochure provides a summary of our strategic partnering interests and priority areas in which we are actively seeking external collaborations.
New approach to externalisation proves successful at J.P. Morgan Healthcare conference
AstraZeneca supported its largest-ever presence at the recent 30th Annual J.P. Morgan Healthcare Conference in San Francisco with a 50 strong team which included representatives from SPBD and our newly appointed R&D strategy heads.
Discover Partnering with AstraZeneca
AstraZeneca works in partnership with bio companies, academic institutions, governments and not-for-profit organisations, sharing skills, knowledge and resources to achieve a common goal: improved health.